InvestorsHub Logo
Followers 31
Posts 912
Boards Moderated 0
Alias Born 12/23/2009

Re: None

Sunday, 08/04/2013 10:48:42 AM

Sunday, August 04, 2013 10:48:42 AM

Post# of 346214
Now that Docetaxel seems to be a good travel companion for its downstream inmune-system effects... what about Sorafenib?... Will it also be substitued for Liver Cancer?... Maybe some of the Mboard experts have an answer.

TIA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News